Baton Rouge-based Amedisys names new CEO _lowres

Paul B. Kusserow, Amedisys Inc. CEO. 

Baton Rouge-based home health company Amedisys posted third-quarter earnings of $72 million, or $2.16 per diluted share, compared to $34.1 million, or $1.03 per diluted share, a year ago.

Baton Rouge-based home health and hospice company Amedisys posted third-quarter earnings of $72 million, or $2.16 per share, compared to $34.1 million, or $1.03 per share, a year ago.

Net service revenue for the company was $544.1 million for the quarter, up from $494.6 million in the third quarter of 2019. Revenue for the home health division was up from $311.5 million to $326 million. The hospice division was up from $162.4 million to $199.7 million. Personal care dropped from $20.7 million to $18.4 million.

The report topped Wall Street expectations. The Zacks Consensus estimate was earnings of $1.27 per share.

“Home health and hospice have shown strong recoveries and returned to growth this quarter, which is no small feat given the continued impact of COIVD-19,” said Paul B. Kusserow, president and chief executive officer.

For 2020, Amedisys, which also has an office in Lafayette, is now forecasting diluted earnings per share in the range of $6.02 to $6.08, with adjusted earnings before interest, tax and deductions between $269 million and $272 million.

Amedisys earnings were down $6.88, or 2.7% a share Tuesday, to close at $248.73.

Acadiana Business Today: Baton Rouge jobs recovery in September mirrors statewide data; see where NOLA, Lafayette stand


Email Timothy Boone at tboone@theadvocate.com.